Labetalol Hydrochloride

Product NDC
0641-6252
11-digit product format
006416252
Labeler code
0641
Product ID
0641-6252_fa0062c6-f563-4d33-a540-fc2c7e91315d
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Labetalol Hydrochloride
Dosage form
INJECTION
Route
INTRAVENOUS
Labeler
Hikma Pharmaceuticals USA Inc.
Application
NDA213330
Marketing category
NDA
Marketing start
2022-03-18
Marketing end
0000-00-00
Substance
LABETALOL HYDROCHLORIDE
Active strength
5 mg/mL
Pharmacologic classes
Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct0641-6252DDiscontinued by firm2026-08-17
excluded packagepackage0641-62520641-6252-10DDiscontinued by firm2026-08-17

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 6 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N213330-001LABETALOL HYDROCHLORIDE IN DEXTROSELABETALOL HYDROCHLORIDE200MG/200ML (1MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-11-09
N213330-002LABETALOL HYDROCHLORIDE IN SODIUM CHLORIDELABETALOL HYDROCHLORIDE100MG/100ML (1MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-11-09
N213330-003LABETALOL HYDROCHLORIDE IN SODIUM CHLORIDELABETALOL HYDROCHLORIDE200MG/200ML (1MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-11-09
N213330-004LABETALOL HYDROCHLORIDE IN SODIUM CHLORIDELABETALOL HYDROCHLORIDE300MG/300ML (1MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-11-09
N213330-005LABETALOL HYDROCHLORIDELABETALOL HYDROCHLORIDE10MG/2ML (5MG/ML)SOLUTION / INTRAVENOUSRLD2022-03-18
N213330-006LABETALOL HYDROCHLORIDELABETALOL HYDROCHLORIDE20MG/4ML (5MG/ML)SOLUTION / INTRAVENOUSRLD, RS2024-08-19

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 5 · 188 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-18 06:07:402026-07N213330-001LABETALOL HYDROCHLORIDE IN DEXTROSE200MG/200ML (1MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-11-09caaa826d4ba7…
2026-08-18 06:07:402026-07N213330-002LABETALOL HYDROCHLORIDE IN SODIUM CHLORIDE100MG/100ML (1MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-11-09caaa826d4ba7…
2026-08-18 06:07:402026-07N213330-003LABETALOL HYDROCHLORIDE IN SODIUM CHLORIDE200MG/200ML (1MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-11-09caaa826d4ba7…
2026-08-18 06:07:402026-07N213330-004LABETALOL HYDROCHLORIDE IN SODIUM CHLORIDE300MG/300ML (1MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-11-09caaa826d4ba7…
2026-08-18 06:07:402026-07N213330-005LABETALOL HYDROCHLORIDE10MG/2ML (5MG/ML)SOLUTION / INTRAVENOUSRLD2022-03-18caaa826d4ba7…
2026-08-18 06:07:402026-07N213330-006LABETALOL HYDROCHLORIDE20MG/4ML (5MG/ML)SOLUTION / INTRAVENOUSRLD, RS2024-08-19caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N213330-001LABETALOL HYDROCHLORIDE IN DEXTROSE200MG/200ML (1MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-11-09011fe1cb6892…
2026-02-19 14:30 UTC2026-02N213330-002LABETALOL HYDROCHLORIDE IN SODIUM CHLORIDE100MG/100ML (1MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-11-09011fe1cb6892…
2026-02-19 14:30 UTC2026-02N213330-003LABETALOL HYDROCHLORIDE IN SODIUM CHLORIDE200MG/200ML (1MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-11-09011fe1cb6892…
2026-02-19 14:30 UTC2026-02N213330-004LABETALOL HYDROCHLORIDE IN SODIUM CHLORIDE300MG/300ML (1MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-11-09011fe1cb6892…
2026-02-19 14:30 UTC2026-02N213330-005LABETALOL HYDROCHLORIDE10MG/2ML (5MG/ML)SOLUTION / INTRAVENOUSRLD2022-03-18011fe1cb6892…
2026-02-19 14:30 UTC2026-02N213330-006LABETALOL HYDROCHLORIDE20MG/4ML (5MG/ML)SOLUTION / INTRAVENOUSRLD, RS2024-08-19011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N213330-001LABETALOL HYDROCHLORIDE IN DEXTROSE200MG/200ML (1MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-11-0931067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N213330-002LABETALOL HYDROCHLORIDE IN SODIUM CHLORIDE100MG/100ML (1MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-11-0931067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N213330-003LABETALOL HYDROCHLORIDE IN SODIUM CHLORIDE200MG/200ML (1MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-11-0931067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N213330-004LABETALOL HYDROCHLORIDE IN SODIUM CHLORIDE300MG/300ML (1MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-11-0931067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N213330-005LABETALOL HYDROCHLORIDE10MG/2ML (5MG/ML)SOLUTION / INTRAVENOUSRLD2022-03-1831067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N213330-006LABETALOL HYDROCHLORIDE20MG/4ML (5MG/ML)SOLUTION / INTRAVENOUSRLD, RS2024-08-1931067a03dcf5…
2025-08-23 18:47 UTC2025-08N213330-001LABETALOL HYDROCHLORIDE IN DEXTROSE200MG/200ML (1MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-11-096a471c1ec25d…
2025-08-23 18:47 UTC2025-08N213330-002LABETALOL HYDROCHLORIDE IN SODIUM CHLORIDE100MG/100ML (1MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-11-096a471c1ec25d…
2025-08-23 18:47 UTC2025-08N213330-003LABETALOL HYDROCHLORIDE IN SODIUM CHLORIDE200MG/200ML (1MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-11-096a471c1ec25d…
2025-08-23 18:47 UTC2025-08N213330-004LABETALOL HYDROCHLORIDE IN SODIUM CHLORIDE300MG/300ML (1MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-11-096a471c1ec25d…
2025-08-23 18:47 UTC2025-08N213330-005LABETALOL HYDROCHLORIDE10MG/2ML (5MG/ML)SOLUTION / INTRAVENOUSRLD2022-03-186a471c1ec25d…
2025-08-23 18:47 UTC2025-08N213330-006LABETALOL HYDROCHLORIDE20MG/4ML (5MG/ML)SOLUTION / INTRAVENOUSRLD, RS2024-08-196a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N213330-001LABETALOL HYDROCHLORIDE IN DEXTROSE200MG/200ML (1MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-11-09fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N213330-002LABETALOL HYDROCHLORIDE IN SODIUM CHLORIDE100MG/100ML (1MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-11-09fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N213330-003LABETALOL HYDROCHLORIDE IN SODIUM CHLORIDE200MG/200ML (1MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-11-09fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N213330-004LABETALOL HYDROCHLORIDE IN SODIUM CHLORIDE300MG/300ML (1MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-11-09fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N213330-005LABETALOL HYDROCHLORIDE10MG/2ML (5MG/ML)SOLUTION / INTRAVENOUSRLD2022-03-18fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N213330-006LABETALOL HYDROCHLORIDE20MG/4ML (5MG/ML)SOLUTION / INTRAVENOUSRLD, RS2024-08-19fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N213330-001LABETALOL HYDROCHLORIDE IN DEXTROSE200MG/200ML (1MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-11-09b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N213330-002LABETALOL HYDROCHLORIDE IN SODIUM CHLORIDE100MG/100ML (1MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-11-09b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N213330-003LABETALOL HYDROCHLORIDE IN SODIUM CHLORIDE200MG/200ML (1MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-11-09b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N213330-004LABETALOL HYDROCHLORIDE IN SODIUM CHLORIDE300MG/300ML (1MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-11-09b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N213330-005LABETALOL HYDROCHLORIDE10MG/2ML (5MG/ML)SOLUTION / INTRAVENOUSRLD2022-03-18b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N213330-006LABETALOL HYDROCHLORIDE20MG/4ML (5MG/ML)SOLUTION / INTRAVENOUSRLD, RS2024-08-19b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N213330-001LABETALOL HYDROCHLORIDE IN DEXTROSE200MG/200ML (1MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-11-0903ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N213330-002LABETALOL HYDROCHLORIDE IN SODIUM CHLORIDE100MG/100ML (1MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-11-0903ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N213330-003LABETALOL HYDROCHLORIDE IN SODIUM CHLORIDE200MG/200ML (1MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-11-0903ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N213330-004LABETALOL HYDROCHLORIDE IN SODIUM CHLORIDE300MG/300ML (1MG/ML)SOLUTION / INTRAVENOUSRLD, RS2020-11-0903ed91905a0d…

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0641-6252-10ML - Milliliter0641-625261759146-aa6e-4309-b5b7-85e61caef28012023-04-07

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0641-6252LABETALOL HYDROCHLORIDE INJECTION [HIKMA PHARMACEUTICALS USA INC.]2Legacy NDC20240410_1c9d496d-cace-4283-82bb-6dcd3828b73e.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Labetalol HydrochlorideLABETALOL HYDROCHLORIDEHikma Pharmaceuticals USA Inc.99a715a0-4579-410c-b102-7ef6fab8db552025-12-19Warnings, Adverse reactionsExact identifier
application applno (NDA): 213330
application number: NDA213330

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
0641-6252-100064162521010 SYRINGE, GLASS in 1 CARTON (0641-6252-10) > 2 mL in 1 SYRINGE, GLASS2022-03-180000-00-00NoNoCurrent